Corona vaccine companies are facing problems, there may be a shortage of volunteers for the trial

Posted on 6th Jan 2021 03:34 pm by rohit kumar

After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.


Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.


'Big challenge for India biotech'

He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.


There is also an ongoing trial of these vaccines

Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.

1 Like 0 Dislike
Previous news Next news
Other news

Bengal Bringing out Homestay Tourism Policy: Official

Kolkata, Feb 5 (IANS) The West Bengal government is bringing out a homestay tourism policy to f

ICC president Kamal sniffs conspiracy in Bangladesh's defeat

Melbourne/New Delhi/Dhaka, March 20 (IANS) International Cricket Council (ICC) president Mustafa

Corona: Has anything changed in India from lockdown to vaccine

Corona: Has anything changed in India from lockdown to vaccine


India's Pri

Sayeed says Peace is must for Kashmir's Development

Jammu, March 1 (IANS) Peace is a must if Jammu and Kashmir has to develop, new Chief Minister M

Congress Releases Manifesto for Delhi Polls

New Delhi, Jan 23 (IANS) Cyber cafes for students, cheap power for domestic consumers and waive

Sign up to write
Sign up now if you have flare of writing..
Login   |   Register
Follow Us
Indyaspeak @ Facebook Indyaspeak @ Twitter Indyaspeak @ Pinterest RSS

Play Free Quiz and Win Cash